Home AbioSci Announces Launch of OmniBrowser™ v3.1, a Major Upgrade to Its Single-Cell Data Mining Platform

AbioSci Announces Launch of OmniBrowser™ v3.1, a Major Upgrade to Its Single-Cell Data Mining Platform

Dec 22, 2021 14:49 CST Updated 14:49
Abiosciences

Life Science Technology Developer

December 21, 2021Abiosciences Launches New Version of Single-Cell Big Data Platform OmniBrowser™ v3.1The v3.1 version is the platform's self...Released v3.0 in early 2021Major updates afterwards, inUser Interface, Analytical Functions, Data Retrievaland other aspects have been further optimized and improved, greatly lowering the threshold for single-cell data analysis and mining, and assisting in drug development and scientific research exploration.
Compared with the v3.0 version, the new version has the following updates:

More practical functions

Cross-dataset Comparison
OmniBrowser™ v3.1 Newly Released Cross-Dataset Comparison Function,Can help users better align single-cell data from a global perspective, obtaining high-precision differences in gene expression and cell population proportions from multiple angles, such as before and after treatment, normal vs. disease states, different stages of disease progression, different types of cancer, and different cancer subtypes.Visualize using t-SNE/UMAP plots, Violin Plots, Bubble Plots, and other forms, while supporting the viewing of Meta information and Marker gene lists for selected datasets.

Deconvolution Analysis
OmniBrowser™ v3.1 supports users in mining TCGA/GTEx data with single-cell precision based on cell types identified from existing datasets.Calculate the proportion of these cell types in specific tumors or specific tissue types within TCGA/GTEx, or the expression of specific genes in these cells in specific tumors or specific tissues.。 

MetaNumberAccording to the analysis
OmniBrowser™ v3.1 incorporates all metadata from single-cell research into the analysis results, supporting usersRetrieve and compare data across multiple dimensions such as before and after treatment, before and after medication, different stages of disease, different cell lines, and different genders to gain deeper insights.。  

Brand New Interface Display

OmniBrowser™ v3.1 has optimized the interface, ensuring a better user experience from visual to search functionality.
图片图片

More comprehensive accumulation of single-cell datasets

Since its release at the beginning of this year, the datasets in OmniBrowser™ have been continuously updated.Now includes 1,350+ cutting-edge single-cell studies, 2,600+ datasets, with over 42 million cells., covering various research fields, including diseases, tumors, development, immunity, neuroscience, cell atlas, etc. Among them,More Than 400 Human Tumor-Related Datasets Provide More References for Clinical Research

Multi-omics Data Support

OmniBrowser™ v3.1 currently supports the 10x Visium platform, TCR data visualization and analysis, allowing users to view the spatial distribution of different subpopulations and TCR clonotype information within samples., helping users access multi-dimensional data information and gain deeper biological insights.

图片

OmniBrowser™ Application Directions:

1) OmniBrowser™ Empowers Drug Discovery

1. Finding New Targets
2. Evaluate Target Effectiveness and Safety

2) OmniBrowser™ Empowers Scientific Research Exploration

1. Quick Search for Data of Interest
2. Rapid Analysis of Differential Expression in Genes of Interest
3. Open New Research Directions

Currently, the brand-new version of the OmniBrowser™ platform is available for trial. Users can apply for a free trial through the following link:

https://omnibrowser.abiosciences.com/#/user/register

The new version release conference will be held in2:00 PM, December 23, 2021To be held, there will be a detailed explanation of the above new features and OmniBrowser™ application scenarios. Welcome to scan the QR code below to register and participate.

Looking forward to your participation

About Abiosciences

Abiosciences is a life science technology company dedicated to the full application of single-cell mechanism research platforms and bioinformatics big data/AI platforms in the diagnosis and treatment of major human diseases such as cancer. By creating precise cellular maps of human diseases and fully utilizing its strong research capabilities, proprietary platforms, and data, Abiosciences aims to identify breakthrough diagnostic and therapeutic targets for diseases and develop disruptive treatment methods.

For more information or services about Abiosciences, you can contact through the communication methods below.

Official Website: www.abiosciences.com.cn

Phone: 010-6256 6819

Email: bd_china@abiosciences.com

WeChat: baiaozhihui01